Franchesca Fonseca-Lanza

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Endothelial Cells

Glycemic Control

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Srijanee Das, Weimin Wang, Murali Ganesan, Franchesca Fonseca-Lanza, Denise A Cobb, Grace Bybee, Yimin Sun, Lili Guo, Brandon Hanson, Samuel M Cohen, Howard E Gendelman, Natalia A Osna, Benson J Edagwa, Larisa Y Poluektova
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science advances 8 (51) (2022)
Srijanee Das, Weimin Wang, Murali Ganesan, Franchesca Fonseca-Lanza, Denise A Cobb, Grace Bybee, Yimin Sun, Lili Guo, Brandon Hanson, Samuel M Cohen, Howard E Gendelman, Natalia A Osna, Benson J Edagwa, Larisa Y Poluektova
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science advances 8 (51) (2022)
Srijanee Das, Weimin Wang, Murali Ganesan, Franchesca Fonseca-Lanza, Denise A Cobb, Grace Bybee, Yimin Sun, Lili Guo, Brandon Hanson, Samuel M Cohen, Howard E Gendelman, Natalia A Osna, Benson J Edagwa, Larisa Y Poluektova
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science advances 8 (51) (2022)
Srijanee Das, Weimin Wang, Murali Ganesan, Franchesca Fonseca-Lanza, Denise A Cobb, Grace Bybee, Yimin Sun, Lili Guo, Brandon Hanson, Samuel M Cohen, Howard E Gendelman, Natalia A Osna, Benson J Edagwa, Larisa Y Poluektova
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science advances 8 (51) (2022)
Srijanee Das, Weimin Wang, Murali Ganesan, Franchesca Fonseca-Lanza, Denise A Cobb, Grace Bybee, Yimin Sun, Lili Guo, Brandon Hanson, Samuel M Cohen, Howard E Gendelman, Natalia A Osna, Benson J Edagwa, Larisa Y Poluektova
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression. Science advances 8 (51) (2022)